Bacteria associated with marginal zone lymphomas.

[1]  S. Franceschi,et al.  European Code against Cancer 4th Edition: Infections and Cancer. , 2015, Cancer epidemiology.

[2]  S. Rosati,et al.  Paediatric nodal marginal zone B‐cell lymphadenopathy of the neck: a Haemophilus influenzae‐driven immune disorder? , 2015, The Journal of pathology.

[3]  D. Heo,et al.  Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma , 2015, Annals of Hematology.

[4]  A. Attygalle,et al.  Helicobacter pylori infection in gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma: a re-evaluation , 2014, Gut.

[5]  S. Pileri,et al.  Prevalence of Achromobacter xylosoxidans in pulmonary mucosa‐associated lymphoid tissue lymphoma in different regions of Europe , 2014, British journal of haematology.

[6]  C. Copie-Bergman,et al.  Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type. , 2014, Seminars in cancer biology.

[7]  L. Medeiros,et al.  Clinicopathologic features of CD5-positive nodal marginal zone lymphoma. , 2013, American journal of clinical pathology.

[8]  N. Schmitz,et al.  ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  C. Copie-Bergman,et al.  Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  C. Copie-Bergman,et al.  Gela histological scoring system for post‐treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice , 2013, British journal of haematology.

[11]  F. Cavalli,et al.  Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  G. Rohde,et al.  More than classical Chlamydia psittaci in urban pigeons. , 2012, Veterinary microbiology.

[13]  C. Doglioni,et al.  Prevalence of chlamydial infection in a series of 108 primary cutaneous lymphomas , 2012, The British journal of dermatology.

[14]  R. Talamini,et al.  Exposure to animals and increased risk of marginal zone B-cell lymphomas of the ocular adnexae , 2012, British Journal of Cancer.

[15]  C. Doglioni,et al.  Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas. , 2011, The oncologist.

[16]  R. Gascoyne,et al.  Genomic profiles of MALT lymphomas: variability across anatomical sites , 2011, Haematologica.

[17]  F. Mégraud,et al.  EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT , 2011, Gut.

[18]  V. Raia,et al.  Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[19]  U. Groß,et al.  Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. , 2010, International journal of medical microbiology : IJMM.

[20]  H. Müller-Hermelink,et al.  A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation‐negative MALT lymphoma of the ocular adnexa and salivary glands , 2009, The Journal of pathology.

[21]  C. Copie-Bergman,et al.  Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial , 2009, British journal of haematology.

[22]  L. Pecciarini,et al.  Chlamydia Infection and Lymphomas: Association Beyond Ocular Adnexal Lymphomas Highlighted by Multiple Detection Methods , 2008, Clinical Cancer Research.

[23]  R. Dummer,et al.  European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. , 2008, Blood.

[24]  P. Neumeister,et al.  Chlamydia psittaci in MALT lymphomas of ocular adnexals: the Austrian experience. , 2008, Leukemia research.

[25]  U. Ryan,et al.  Prevalence of Cryptosporidium and Giardia species in animals in irrigation catchments in the southwest of Australia. , 2008, Experimental parasitology.

[26]  A. Nicholson,et al.  Chlamydiae and Mycoplasma infections in pulmonary MALT lymphoma , 2007, British Journal of Cancer.

[27]  P. Monari,et al.  Borrelia burgdorferi-Associated Primary Cutaneous Marginal-Zone B-Cell Lymphoma: A Case Report , 2007, Dermatology.

[28]  W. Fischbach,et al.  Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series , 2007, Gut.

[29]  C. Prinz,et al.  Inhibition of T-Cell Proliferation by Helicobacter pylori γ-Glutamyl Transpeptidase , 2007 .

[30]  C. Doglioni,et al.  Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. , 2006, Journal of the National Cancer Institute.

[31]  Hsiu‐Po Wang,et al.  Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  B. Coiffier,et al.  Management of marginal zone lymphomas , 2006, Current treatment options in oncology.

[33]  O. Hermine,et al.  Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. , 2006, Blood.

[34]  S. Pileri,et al.  Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  G. Byrne,et al.  Chlamydia and programmed cell death. , 2006, Current opinion in microbiology.

[36]  R. Dummer,et al.  Intra-lesional low-dose interferon α2a therapy for primary cutaneous marginal zone B-cell lymphoma , 2006, Leukemia & lymphoma.

[37]  K. Ohshima,et al.  p16/INK4a gene methylation is a frequent finding in pulmonary MALT lymphomas at diagnosis , 2005, Modern Pathology.

[38]  E. Noordijk,et al.  Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases. , 2005, Archives of dermatology.

[39]  C. Doglioni,et al.  Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  Marc Lecuit,et al.  [Immunoproliferative small intestinal disease associated with Campylobacter jejuni]. , 2005, Medecine et maladies infectieuses.

[41]  Honglin Zhou,et al.  Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. , 2005, Cancer cell.

[42]  T. Al-Saleem,et al.  Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. , 2005, Blood.

[43]  J. Hampe,et al.  IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection. , 2004, Blood.

[44]  D. Ojcius,et al.  Chlamydia and apoptosis: life and death decisions of an intracellular pathogen , 2004, Nature Reviews Microbiology.

[45]  Hui-Ting Chen,et al.  Helicobacter pylori enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in human gastric epithelial cells. , 2004, World journal of gastroenterology.

[46]  M. Boiocchi,et al.  Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. , 2004, Journal of the National Cancer Institute.

[47]  S. Barrans,et al.  Cutaneous B‐cell lymphoma: Pathological spectrum and clinical outcome in 51 consecutive patients , 2004, American journal of hematology.

[48]  P. Isaacson,et al.  Bacterial infection and MALT lymphoma. , 2004, The New England journal of medicine.

[49]  A. Chott,et al.  Frequency of Chromosomal Aberrations Involving MALT1 in Mucosa-Associated Lymphoid Tissue Lymphoma in Patients with Sjögren’s Syndrome , 2004, Clinical Cancer Research.

[50]  T. Kuo,et al.  Combination of Adult Inclusion Conjunctivitis and Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma in a Young Adult , 2004, Cornea.

[51]  R. Harding,et al.  Genetic Diversity of Campylobacter jejuni Isolates from Farm Animals and the Farm Environment , 2003, Applied and Environmental Microbiology.

[52]  F. Cavalli,et al.  Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. , 2003, Blood.

[53]  A Graham Pockley,et al.  Heat shock proteins as regulators of the immune response , 2003, The Lancet.

[54]  K. Maclennan,et al.  Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. , 2003, Blood.

[55]  F. Vandenesch,et al.  Borrelia-associated primary cutaneous MALT lymphoma in a nonendemic region. , 2003, The American journal of surgical pathology.

[56]  G. Ferns,et al.  Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. , 2003, Atherosclerosis.

[57]  L. Cerroni,et al.  Borrelia burgdorferi-associated lymphocytoma cutis simulating a primary cutaneous large B-cell lymphoma. , 2002, Journal of the American Academy of Dermatology.

[58]  F. Cavalli,et al.  Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. , 2002, Blood.

[59]  R. Peeling,et al.  Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. , 2002, The Journal of infectious diseases.

[60]  H. Kerl,et al.  Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas. , 2001, The Keio journal of medicine.

[61]  M. Asaka,et al.  Immunoglobulin G1 Antibody Response toHelicobacter pylori Heat Shock Protein 60 Is Closely Associated with Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma , 2001, Clinical Diagnostic Laboratory Immunology.

[62]  N. Nakamura,et al.  Immunoglobulin heavy chain gene analysis of ocular adnexal extranodal marginal zone B-cell lymphoma. , 2001, Investigative ophthalmology & visual science.

[63]  A. van Belkum,et al.  Sequence Typing Confirms that Campylobacter jejuni Strains Associated with Guillain-Barré and Miller-Fisher Syndromes Are of Diverse Genetic Lineage, Serotype, and Flagella Type , 2001, Journal of Clinical Microbiology.

[64]  C. Copie-Bergman,et al.  Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type , 2001, American Journal of Gastroenterology.

[65]  G. Mckhann,et al.  Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barré syndrome and gastroenteritis. , 2001, The Journal of infectious diseases.

[66]  T. Yoshino,et al.  Clinical, Histopathological, and Immunogenetic Analysis of Ocular Adnexal Lymphoproliferative Disorders: Characterization of MALT Lymphoma and Reactive Lymphoid Hyperplasia , 2001, Modern Pathology.

[67]  M. Seto,et al.  Bcl10 and MALT1, Independent Targets of Chromosomal Translocation in MALT Lymphoma, Cooperate in a Novel NF-κB Signaling Pathway* , 2001, The Journal of Biological Chemistry.

[68]  G. Pamuk,et al.  Should we suppress the antigenic stimulus in IPSID for lifelong , 2000 .

[69]  P. Batstone,et al.  Primary Cutaneous B-Cell Lymphoma and Borrelia burgdorferi Infection in Patients From the Highlands of Scotland , 2000, The American journal of surgical pathology.

[70]  F. Cavalli,et al.  Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. , 2000, Human pathology.

[71]  G. Salles,et al.  Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. , 2000, Blood.

[72]  M. D’Elios,et al.  Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. , 1999, Gastroenterology.

[73]  S. Jelić,et al.  Positive serology for Lyme disease Borrelias in primary cutaneous B‐cell lymphoma: a study in 22 patients; is it a fortuitous finding? , 1999, Hematological oncology.

[74]  H. Stein,et al.  Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa. , 1999, Investigative ophthalmology & visual science.

[75]  M. Oldstone.  Molecular mimicry and immune‐mediated diseases , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[76]  S. Pileri,et al.  B‐CELL LYMPHOMA OF MALT TYPE: A REVIEW WITH SPECIAL EMPHASIS ON DIAGNOSTIC AND MANAGEMENT PROBLEMS OF LOW‐GRADE GASTRIC TUMOURS , 1998, British journal of haematology.

[77]  H. Kerl,et al.  Infection by Borrelia burgdorferi and cutaneous B‐cell lymphoma , 1997, Journal of cutaneous pathology.

[78]  I. Soykan,et al.  Five‐year results of the treatment of 23 patients with immunoproliferative small intestinal disease , 1997, Cancer.

[79]  L. Cerroni,et al.  Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. , 1997, Journal of the American Academy of Dermatology.

[80]  R. Peeling,et al.  Chlamydiae as pathogens: new species and new issues. , 1996, Emerging infectious diseases.

[81]  J. Parsonnet.  Gastric adenocarcinoma and Helicobacter pylori infection. , 1994, The Western journal of medicine.

[82]  T. C. Diss,et al.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori , 1993, The Lancet.

[83]  P. Isaacson,et al.  The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori , 1993, The Lancet.

[84]  M. Chao,et al.  Leukemic manifestation in a case of alpha‐chain disease with multiple polypoid intestinal lymphocytic lymphoma , 1992, American journal of hematology.

[85]  C. Doglioni,et al.  High incidence of primary gastric lymphoma in northeastern Italy , 1992, The Lancet.

[86]  H. Stein,et al.  Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. , 1991, Journal of the American Academy of Dermatology.

[87]  T. Al-Saleem.  EVIDENCE OF ACQUIRED IMMUNE DEFICIENCIES IN MEDITERRANEAN LYMPHOMA A Possible Aetiological Link , 1978, The Lancet.

[88]  Y. Beyth,et al.  ALPHA-FETOPROTEIN DURING MID-TRIMESTER INDUCED ABORTION , 1975, The Lancet.

[89]  R. Advani,et al.  The World Health Organization Classification of Lymphoid Neoplasms , 2013 .

[90]  K. Stamatopoulos,et al.  Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation , 2012, Leukemia.

[91]  M. Binder,et al.  Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[92]  L. Pecciarini,et al.  Chlamydia-psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[93]  C. Mancini,et al.  Emerging cystic fibrosis pathogens: incidence and antimicrobial resistance. , 2007, The new microbiologica.

[94]  A. Tsapis,et al.  Immunoproliferative small intestinal disease (IPSID): Relationships with α-chain disease and “Mediterranean” lymphomas , 2004, Springer Seminars in Immunopathology.

[95]  Marc Lecuit,et al.  Immunoproliferative small intestinal disease associated with Campylobacter jejuni. , 2004, The New England journal of medicine.

[96]  H. Kerl,et al.  Die Therapie der primären kutanen B-Zell-Lymphome , 2000, Der Hautarzt.

[97]  P. Saikku,et al.  Chlamydial antibodies in an elderly Finnish population. , 1999, Scandinavian journal of infectious diseases.

[98]  M. Bowie,et al.  Clinical and pathological evolution of alpha chain disease to immunoblastic lymphoma and response to COMP chemotherapy. , 1988, Medical and pediatric oncology.